Sample forms, questionnaires, and certificate for due diligence into proposed agents and intermediaries, with a focus on the US Foreign Corrupt Practices Act (FCPA), and sample exclusive agency agreement for an agent to sell a company's service in a territory.
This article, developed by Womble Bond Dickinson, continues the 11- month countdown to develop business compliance strategies for three new omnibus privacy laws coming in 2023: January 1: the California Consumer Privacy Rights Act (which amends the existing CCPA) and the Virginia Consumer Data Protection Act; July1: the Colorado Privacy Act. With 8 months to go, this alert compares the individual rights granted under each of the state privacy laws.
This Latham & Watkins article analyzes the proposed rules and advises SEC registrants on how to prepare for compliance with the proposed cyber rules in May of 2022.
A basic outline of an attorney-client privilege and work product doctrine.
This is a sample sales representative agreement between a company and a sales agent, for the sale of the company's telecom products.
Canada is an attractive market for pharmaceutical manufacturers. Most Canadian consumers have some form of drug coverage through government programs and/or private insurance. Below are ten patent and regulatory topics that in-house counsel need to know before bringing an innovative product to Canada.
Editor's note: This article was updated to reflect recent developments; the original version of this article was published on December 16, 2020.
The September 2017 amendments to the Patented Medicines (Notice of Compliance) Regulations introduced a new scheme for pharmaceutical patent linkage litigation in Canada. That scheme is now much closer to the United States' (US) Hatch-Waxman scheme, but with remaining key differences that are explained in this chart.
Amendments to the Canadian Patent Act and enactment of the Certificate of Supplementary Protection Regulations flowing from the Canada-European Union (EU) Comprehensive Economic and Trade Agreement introduced a new framework in Canada for the issuance of Certificates of Supplementary Protection (CSPs).
This chart compare key aspects of the two regimes, Canada's and the EU's.
Patented medicine regulations in Canada can be complex and the review process is fast-paced. In this Top Ten, in-house counsel will learn the essential points of how to prepare for the "Regulations" review. Editor's note: This article was updated to reflect recent developments; a prior version of this article was published on August 6, 2020.
This is a confidentiality agreement between two companies who have a preliminary interest in exploring a merger or other combination of companies.